Source: International Journal of Molecular Sciences. Unidade: ICB
Subjects: IMUNOLOGIA, INFLAMAÇÃO, CÉLULAS DENDRÍTICAS, VITAMINA D, DOENÇAS DO SISTEMA NERVOSO CENTRAL, LINFONODOS DE ANIMAL, CITOCINAS, MICRORNAS, ENCEFALOMIELITE ANIMAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MIMURA, Luiza Ayumi Nishiyama et al. Preclinical therapy with Vitamin D3 in experimental encephalomyelitis: efficacy and comparison with Paricalcitol. International Journal of Molecular Sciences, v. 22, n. 4, p. 1-21, 2021Tradução . . Disponível em: https://doi.org/10.3390/ijms22041914. Acesso em: 18 out. 2024.APA
Mimura, L. A. N., Silva, T. F. de C. F., Oliveira, L. R. C. de, Ishikawa, L. L. W., Borim, P. A., Machado, C. de M., et al. (2021). Preclinical therapy with Vitamin D3 in experimental encephalomyelitis: efficacy and comparison with Paricalcitol. International Journal of Molecular Sciences, 22( 4), 1-21. doi:10.3390/ijms22041914NLM
Mimura LAN, Silva TF de CF, Oliveira LRC de, Ishikawa LLW, Borim PA, Machado C de M, Horta Junior J de A de C e, Fonseca DM da, Sartori A. Preclinical therapy with Vitamin D3 in experimental encephalomyelitis: efficacy and comparison with Paricalcitol [Internet]. International Journal of Molecular Sciences. 2021 ; 22( 4): 1-21.[citado 2024 out. 18 ] Available from: https://doi.org/10.3390/ijms22041914Vancouver
Mimura LAN, Silva TF de CF, Oliveira LRC de, Ishikawa LLW, Borim PA, Machado C de M, Horta Junior J de A de C e, Fonseca DM da, Sartori A. Preclinical therapy with Vitamin D3 in experimental encephalomyelitis: efficacy and comparison with Paricalcitol [Internet]. International Journal of Molecular Sciences. 2021 ; 22( 4): 1-21.[citado 2024 out. 18 ] Available from: https://doi.org/10.3390/ijms22041914